Ginkgo Bioworks Holdings (DNA) Return on Sales (2020 - 2025)
Ginkgo Bioworks Holdings' Return on Sales history spans 6 years, with the latest figure at 2.42% for Q4 2025.
- For Q4 2025, Return on Sales rose 3.0% year-over-year to 2.42%; the TTM value through Dec 2025 reached 1.84%, up 57.0%, while the annual FY2025 figure was 1.84%, 57.0% up from the prior year.
- Return on Sales reached 2.42% in Q4 2025 per DNA's latest filing, down from 2.08% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.63% in Q3 2024 to a low of 10.81% in Q4 2021.
- Average Return on Sales over 5 years is 3.51%, with a median of 2.44% recorded in 2024.
- Peak YoY movement for Return on Sales: plummeted -942bps in 2021, then soared 905bps in 2022.
- A 5-year view of Return on Sales shows it stood at 10.81% in 2021, then skyrocketed by 84bps to 1.76% in 2022, then crashed by -246bps to 6.09% in 2023, then soared by 60bps to 2.45% in 2024, then rose by 1bps to 2.42% in 2025.
- Per Business Quant, the three most recent readings for DNA's Return on Sales are 2.42% (Q4 2025), 2.08% (Q3 2025), and 1.22% (Q2 2025).